Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

High Potency Active Pharmaceutical Ingredients (APIs) Market to Reach $34.8 Billion by 2025: Key Players are Bristol-Myers Squibb, Sigma-Aldrich Corporation, Pfizer Inc & Lonza - Research and Markets

Research and Markets
Posted on: 22 Aug 17

The "High Potency Active Pharmaceutical Ingredients (APIs) Market, 2014-2025" report has been added to Research and Markets' offering.

The global HPAPIs market is expected to reach USD 34.8 billion by 2025, according to this new report. Increasing number of new entrants producing fast relief therapeutics in emerging countries of India and China is anticipated to boost the demand for High potency active pharmaceutical ingredients (HPAPIs) over the forecast period.

In addition, supportive government regulations for commercialization and research and development of novel drug molecules are projected to drive the industry growth. Extensive capital investments required for development of production facility has lead to increase in contract manufacturing activities for HPAPIs during the forecast period.

Biotech HPAPI segment is expected to be the fastest growing and is expected to grow at a lucrative growth ratedue torising demand for cancer drugs and fueling research and developmentactivities pertaining to it.

Innovative drug market dominated the overall drug type in 2016. Generic drug segment is expected to be the fastest growing segment. The factors attributing to its growth are patent expiration of various drugs and increasing demand for the cancer treatment.

Contact outsourcing segment is anticipated to show lucrative growth as major pharmaceuticals are focused on rigorous research and development activities for new drug development.

Companies Mentioned

  • Eli Lily and Company
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Roche Diagnostics Ltd.
  • Sanofi
  • Hospira, Inc.
  • Covidien plc
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • Sigma Aldrich Corporation
  • Bayer AG
  • Carbogen Amcis AG
  • Lonza
  • Teva Pharmaceutical Industries Ltd.

Key Topics Covered:

1 Methodology and Scope

2. Executive Summary

3. HPAPI Market Variables, Trends & Scope

4. HPAPI Market: Product Estimates & Trend Analysis

5. HPAPI Market: Manufacturer Estimates & Trend Analysis

6. HPAPI Market: Drug Type Estimates & Trend Analysis

7. HPAPI Market: Therapeutic Application Estimates & Trend Analysis

8. HPAPI Market: Regional Estimates & Trend Analysis, by Product, Manufacturer, Drug Type, and Therapeutic Application

9. Competitive Landscape

For more information about this report visit

View source version on

Business Wire

Last updated on: 22/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.